Enveric Biosciences Inc (ENVB) Stock Price, Quote & News

Company Profile

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules...

Industry: Biotechnology

Sector: Healthcare

Website: www.enveric.com

Address:

245 First Street, Riverview II 18 th Floor, Cambridge, United States

VegasOracle Nov. 14 at 9:34 PM

$ENVB https://www.enveric.com/news/enveric-biosciences-reports-third-quarter-2025-financial-and-corporate-results/ Human trials in 2026

0 · Reply

RBLUCKY Nov. 14 at 9:20 PM

$ENVB Quarter 2025 Financial Results Net loss attributable to common stockholders was $3.4 million for the quarter ending September 30, 2025, or $10.81 per share, compared to a net loss of $2.1 million, or $43.10 per share, for the same period in 2024.

0 · Reply

TradingEmpires Nov. 14 at 8:31 PM

$ENVB $IPW $CLIK $JFBR $UPC.X

0 · Reply

Dr_ChimRichalds Nov. 14 at 7:10 PM

$ENVB near 52wk low with potential 'first in class' treatment.. 👀

0 · Reply

GladiatorSwings Nov. 14 at 6:51 PM

This will be the LAST TIME I will post until one of my picks will run HUGE. Small caps looking grim right now. Holding: $ENVB 550k float - at 5.30$ $IPW 400k float - at 9.50$ $CLIK 610k float - at 6.50$ $JFBR 660k float - at 2.13$ $UPC.X 559k float - at 3.64$ Will not post anything until one of them runs HUGE. Mark this post. Radio silence until then. Good luck bulls and have a nice weekend! :)

3 · Reply

GladiatorSwings Nov. 14 at 6:45 PM

$ENVB Added 2k shares here down at 5.30. Waiting for a PR. 515k float ENVB.

0 · Reply

MakeM0ney_444 Nov. 14 at 6:32 PM

$ENVB so ummm…?

0 · Reply

Love_To_Learn Nov. 14 at 1:47 PM

$GCTK $PBM $ENVB $BDRX $AIFU shift

0 · Reply

_SquidGains_ Nov. 13 at 11:31 PM

$ABP $NCEL $NVA $ENVB .

0 · Reply

Dodo80 Nov. 13 at 5:39 PM

$ENVB Triple bottom and....

1 · Reply

Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results

Oct 23, 2025, 8:00 AM EDT - 22 days ago

Enveric Biosciences Announces Reverse Stock Split

Oct 16, 2025, 8:30 AM EDT - 4 weeks ago

Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

Oct 15, 2025, 8:00 AM EDT - 4 weeks ago

Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

Oct 14, 2025, 9:00 AM EDT - 4 weeks ago

Enveric Biosciences to Explore Digital Asset Treasury Opportunities

Oct 2, 2025, 8:45 AM EDT - 6 weeks ago

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

Sep 18, 2025, 4:30 PM EDT - 2 months ago

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

Sep 17, 2025, 9:24 AM EDT - 2 months ago

Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

Sep 17, 2025, 8:00 AM EDT - 2 months ago

Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery

Sep 16, 2025, 8:45 AM EDT - 2 months ago

Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission

Sep 3, 2025, 8:30 AM EDT - 2 months ago

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:30 AM EDT - 2 months ago

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA

Aug 28, 2025, 8:30 AM EDT - 2 months ago

Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications

Aug 14, 2025, 8:00 AM EDT - 3 months ago

Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

Jul 23, 2025, 8:03 AM EDT - 4 months ago

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

Jul 15, 2025, 9:03 AM EDT - 4 months ago

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

Jun 24, 2025, 9:03 AM EDT - 5 months ago

Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

Jun 16, 2025, 10:46 AM EDT - 5 months ago

Enveric Biosciences Announces Participation in 2025 BIO International Convention

Jun 10, 2025, 9:03 AM EDT - 5 months ago

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders

Jun 3, 2025, 9:00 AM EDT - 5 months ago

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds

May 28, 2025, 9:03 AM EDT - 6 months ago

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003

May 20, 2025, 8:00 AM EDT - 6 months ago

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease

May 14, 2025, 4:15 PM EDT - 6 months ago

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results

Mar 31, 2025, 8:00 AM EDT - 8 months ago

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

Mar 17, 2025, 1:40 PM EDT - 8 months ago

Enveric Biosciences Participating in BIO-Europe Spring®

Mar 6, 2025, 10:00 AM EST - 9 months ago

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

Feb 27, 2025, 9:30 AM EST - 9 months ago

Enveric Biosciences CEO Issues Letter to Shareholders

Feb 25, 2025, 1:30 PM EST - 9 months ago

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent

Feb 4, 2025, 8:00 AM EST - 10 months ago

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

Feb 3, 2025, 5:00 PM EST - 10 months ago

Enveric Biosciences Announces Closing of $5 Million Public Offering

Jan 30, 2025, 8:14 PM EST - 10 months ago

Enveric Biosciences Announces Pricing of $5 Million Public Offering

Jan 30, 2025, 4:01 PM EST - 10 months ago

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office

Jan 6, 2025, 8:30 AM EST - 11 months ago

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”

Dec 2, 2024, 8:00 AM EST - 1 year ago

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds

Nov 25, 2024, 9:00 AM EST - 1 year ago

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior

Nov 14, 2024, 4:05 PM EST - 1 year ago

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

Nov 12, 2024, 9:00 AM EST - 1 year ago

Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002

Nov 4, 2024, 10:36 AM EST - 1 year ago

Enveric Biosciences Announces Broad Range of Patent Issuances

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003

Sep 26, 2024, 8:30 AM EDT - 1 year ago

Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop

Sep 25, 2024, 8:30 AM EDT - 1 year ago

Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Aries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries' License for Treatment of Radiation Dermatitis and Other Conditions

Aug 12, 2024, 5:30 PM EDT - 1 year ago

Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally

Jul 15, 2024, 9:02 AM EDT - 1 year ago

Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Announces Patent Granted for Drug Candidate

Jun 28, 2024, 8:00 AM EDT - 1 year ago

Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)

MBIO

Jun 25, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate

May 30, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences to Participate in BIO International Convention 2024

VegasOracle Nov. 14 at 9:34 PM

$ENVB https://www.enveric.com/news/enveric-biosciences-reports-third-quarter-2025-financial-and-corporate-results/ Human trials in 2026

0 · Reply

RBLUCKY Nov. 14 at 9:20 PM

0 · Reply

TradingEmpires Nov. 14 at 8:31 PM

$ENVB $IPW $CLIK $JFBR $UPC.X

0 · Reply

Dr_ChimRichalds Nov. 14 at 7:10 PM

$ENVB near 52wk low with potential 'first in class' treatment.. 👀

0 · Reply

GladiatorSwings Nov. 14 at 6:51 PM

3 · Reply

GladiatorSwings Nov. 14 at 6:45 PM

$ENVB Added 2k shares here down at 5.30. Waiting for a PR. 515k float ENVB.

0 · Reply

MakeM0ney_444 Nov. 14 at 6:32 PM

$ENVB so ummm…?

0 · Reply

Love_To_Learn Nov. 14 at 1:47 PM

$GCTK $PBM $ENVB $BDRX $AIFU shift

0 · Reply

_SquidGains_ Nov. 13 at 11:31 PM

$ABP $NCEL $NVA $ENVB .

0 · Reply

Dodo80 Nov. 13 at 5:39 PM

$ENVB Triple bottom and....

1 · Reply

_NotFinancialAdvice_ Nov. 13 at 1:38 AM

in today's news at $ENVB, dilution and r-s. Come on now and vote... Allow us to add 5 million shares, and allow us right-away to r-s when we please!

0 · Reply

Love_To_Learn Nov. 12 at 11:26 PM

$ENVB need to detonate a manual update soonish

1 · Reply

Dodo80 Nov. 12 at 4:50 PM

$ENVB Today we can close over 6.15

0 · Reply

_ReddBullyz Nov. 12 at 4:02 PM

Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $ENVB $YYAI $SONM $GURE Roster!

0 · Reply

exile0002 Nov. 12 at 11:19 AM

$PBM $ADTX $SGBX $ENVB $UPC.X $ADTX one of most diluted stocks in entire market and it will not end !!!!!

0 · Reply

sophia_green07 Nov. 12 at 11:11 AM

$ENVB primed for another leg up!!

0 · Reply

PaulLaurent Nov. 12 at 10:39 AM

📉🧾 Stocks with the Lowest Outstanding Shares 🧾📉 $PBM $ADTX $SGBX $ENVB $UPC.X

0 · Reply

Eliezer_Griffin_84 Nov. 12 at 9:53 AM

$ENVB micro-cap biotech. Catalyst tape only. If halt-resume shows high imbalance, scalp +15–25% spikes. Small size, hard stops. ⚠️

0 · Reply

Dodo80 Nov. 11 at 5:20 PM

$ENVB No news, no volume and price flat 🤔🤔

0 · Reply

stayput Nov. 11 at 12:04 AM

$ENVB I grabbed 1,400 more.

1 · Reply

Love_To_Learn Nov. 10 at 8:21 PM

$ENVB $PRPO $NUWE $SINT $PULM SHIFT

0 · Reply

Mikeqb20 Nov. 10 at 8:20 PM

$ENVB BUY NOW!

1 · Reply

Market Cap	2.83M
Revenue (ttm)	0.00
Net Income (ttm)	-9.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	27,500
Avg Vol	89,820
Day's Range	N/A - N/A
Shares Out	518,000.00
Stochastic %K	3%
Beta	0.58
Analysts	Strong Buy
Price Target	$10.00